PATENT CLAIM ANALYSIS

Application Number: 16297386
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "312000"]

Abstract:
The present invention provides 1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yl)oxy-6-methoxyquinolin-7-yl]oxy]methyl]cyclopro-pylamine used for combating a tumor. Specially, the present invention refers to method for treating tumor, pharmaceutical composition and medicinal kit related to the described compound. Administrating the compound with a suitable dosage regimen can not only make the patient's plasma concentration maintain the level of 100 ng/ml or lower, but also achieve effects of treatments and obtain benefits for various tumours.

Claim (Index 10):
The method according to  claim 7 , wherein the pharmaceutical composition is tablets or capsules.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 99.0
- Lexical Diversity: 1.33846
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15315655', '14021033', '15084712', '15953184', '15315647']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7376541969182917
- 35 USC 102 Novelty (BERT): 0.561741397817168
- Combined Prediction Score: 0.7200629170081794
- Mean Citation Score: 267.651468
- Max Citation Score: 455.50256
- Similarity Product: 281.2699290007019

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test